Literature DB >> 7579432

Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.

W E Fibbe1, D P Heemskerk, L Laterveer, J F Pruijt, D Foster, K Kaushansky, R Willemze.   

Abstract

The recent cloning of the ligand of the c-Mpl hematopoietin receptor has indicated a major role for this cytokine in the development of megakaryocytes. In this study we have applied c-Mpl ligand (thrombopoietin [TPO]) in the setting of syngeneic transplantation in an attempt to accelerate the reconstitution of platelets. Donor mice were treated with 20 kilounits (kU)/d TPO intraperitoneally (ip) for 5 days. This resulted in a 2.5-fold increment in platelet counts from 1,119 x 10(9)/L to 2,582 x 10(9)/L (mean, n = 7). Total numbers of hematopoietic progenitor cells in bone marrow (BM) and spleen, as assessed in a colony-forming unit-granulocyte erythroid monocyte macrophage (CFU-GEMM) colony assay (55.3 v 38.6 x 10(3) CFU/femur; 27.3 v 16.3 x 10(3) CFU/spleen, mean, n = 7) as well as total numbers of burst-forming unit-erythroid (BFU-E) (24.0 v 16.4 x 10(3)/femur; 10.2 v 1.9 x 10(3)/spleen, mean, n = 7), were significantly higher in TPO-treated donors than in saline-treated controls. Female Balb-C mice were lethally (8.5 Gy) irradiated and transplanted with 10(5) BM cells. After transplantation, groups of mice were treated with recombinant murine TPO at a dose of 20 to 30 kU/d ip or subcutaneously (SC) for 5 to 14 days. Using this dose and schedule, TPO did not stimulate the recovery of platelets in comparison with control animals transplanted with equal cell numbers but given vehicle alone. In other experiments, 10(5) BM cells were procured from TPO-treated donor mice and transplanted into lethally irradiated recipient mice. In comparison with animals transplanted with an equal number of BM cells derived from saline-treated controls, recipients of TPO-treated BM cells had significantly faster platelet recovery and higher platelet nadir counts (88 v 30 x 10(9)/L, mean, n = 20). Transplantation of TPO-treated BM cells also resulted in an accelerated recovery of erythrocytes and increased erythrocyte nadir counts (7.2 v 5.0 x 10(12)/L, mean, n = 20). At the day of platelet nadir (day 12 after transplantation) these animals had higher numbers of BFU-Es (770 v 422, mean, n = 5) in the marrow and also had higher reticulocyte counts (44 / 1000 v 8 / 1000 mean, n = 5) in the blood. Therefore, the accelerated recovery of erythrocytes may be a direct effect of TPO on erythropoiesis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579432

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Are there more tricks in the bag for treating thrombocytopenia?

Authors:  Andrew D Leavitt
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia.

Authors:  Hirohide Kawasaki; Takahide Nakano; Urara Kohdera; Yohnosuke Kobayashi
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

3.  Thrombopoietin expands hematopoietic stem cells after transplantation.

Authors:  Norma Fox; Greg Priestley; Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 4.  New thrombopoietic growth factors.

Authors:  David J Kuter
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

5.  Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor.

Authors:  M W Kieran; A C Perkins; S H Orkin; L I Zon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

6.  Platelet and peripheral white blood cell counts at diagnosis predict the response of adult immune thrombocytopenia to recombinant human interleukin-11: A retrospective, single-center, case-control study.

Authors:  Chenghao Jin; Yulu Wang; Hongbo Cheng; Haiyun Liu; Tingting Liu; Bo Ke; Anna Li; Liu Yang; Qingxiu Zhu; Weirong Ding; Minzhi Luo; Yujing Wei; Chunfang Kong
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 7.  Exogenous endothelial cells as accelerators of hematopoietic reconstitution.

Authors:  J Christopher Mizer; Thomas E Ichim; Doru T Alexandrescu; Constantin A Dasanu; Famela Ramos; Andrew Turner; Erik J Woods; Vladimir Bogin; Michael P Murphy; David Koos; Amit N Patel
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

8.  The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Authors:  John M Ninos; Leigh C Jefferies; Christopher R Cogle; William G Kerr
Journal:  J Transl Med       Date:  2006-02-16       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.